Calcionics Appoints Daniel O. Wilds Executive Chairman
Calcionics Corporation announced the appointment of Daniel O. Wilds as Executive Chairman of the Company’s Board of Directors. Mr. Wilds is a senior healthcare executive with extensive private and public company leadership and board experience.
Mr. Wilds recently retired as CEO of SCOLR Pharma, Inc. He previously served as Chairman and CEO at Northwest Biotherapeutics, Inc., as CEO at Shiloov Biotechnologies (USA), as CEO of Adeza BioMedical, and as CEO of Medisense, Inc. Mr. Wilds started his career at Baxter International in 1968 where he held various domestic and international senior management positions for more than 20 years including being president of Baxter’s chemotherapy service business and of Travenol-Genentech, a joint venture between Baxter and Genentech. He currently serves on the board of directors of Helix BioMedix, Inc.
Most read news
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Avastin Approved in Europe for First-line Treatment of Patients With Advanced Lung Cancer - First Medicine Shown to Extend Survival Beyond One Year in Previously Untreated Lung Cancer Patients

Female moths use olfactory signals to choose the best egg-laying sites - Small changes in the composition of green leaf volatiles induced by herbivory guide ovipositing female moths to unattacked plants
Epistem announce collaboration with Humanetics Corporation
